Brief: Alzinova Announces Upcoming Clinical Study With Vaccine Candidate ALZ-101

Alzinova AB

04/11/2020 12:17

Nov 4 (Reuters) - Alzinova AB  ALZ.ST :
    * ANNOUNCES UPCOMING CLINICAL STUDY WITH VACCINE CANDIDATE
ALZ-101
AT SCIENTIFIC CONGRESS CLINICAL TRIALS IN ALZHEIMER'S DISEASE
(CTAD)
    * PLANNED STUDY WILL BE CONDUCTED IN PATIENTS WITH EARLY
ALZHEIMER'S DISEASE AND IS EXPECTED TO COMMENCE DURING Q2 2021.
    * PRIMARY OBJECTIVE IS TO ASSESS TOLERABILITY AND ANY
UNEXPECTED
ADVERSE EFFECTS OF ALZ-101 VACCINE CANDIDATE

Source text for Eikon:  ID:nWkrZ1P33 
Further company coverage:  ALZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))